⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1387260 | 0.62 | — | — | |
| SCHEMBL247881 | 0.59 | — | — | |
| SCHEMBL7380936 | 0.59 | — | — | |
| SCHEMBL3004113 | 0.59 | — | — | |
| SCHEMBL50608 | 0.58 | — | — | |
| Methylsulfanylmethane SCHEMBL19639841 | 0.58 | — | — | |
| SCHEMBL3454770 | 0.58 | — | — | |
| Iodide SCHEMBL9413542 | 0.54 | — | — | |
| Iodide SCHEMBL2784177 | 0.54 | — | — | |
| Hydrochloric Acid SCHEMBL11034699 | 0.54 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7301029-B2 | Bipyridine Derivatives | FUJIFILM FINECHEMICALS CO., LTD. (JP) | 2007-11-27 | — | — | US | disclosed |
| US-20060293372-A1 | Beta-sheet mimetics and methods relating to the use thereof | MYRIAD GENETICS, INC. (US) | 2006-12-28 | — | — | US | disclosed |
| EP-1661566-A2 | Use of beta-sheet mimetics as protease and kinase inhibitors and as inhibitors of transcription factors | MYRIAD GENETICS, INC. (US) | 2006-05-31 | — | — | EP | disclosed |
| EP-0915700-B1 | USE OF BETA-SHEET MIMETICS AS PROTEASE AND KINASE INHIBITORS AND AS INHIBITORS OF TRANSCRIPTION FACTORS | MYRIAD GENETICS INC (US) | 2006-03-22 | — | — | EP | disclosed |
| US-20050085642-A1 | Novel bipyridine derivatives | SANKIO CHEMICAL CO., LTD. | 2005-04-21 | — | — | US | disclosed |
| EP-0933993-A4 | SUBSTITUTED CYCLOPENTANE COMPOUNDS USEFUL AS NEURAMINIDASE INHIBITORS | BIOCRYST PHARM INC (US) | 2004-09-08 | — | — | EP | disclosed |
| US-20030027819-A1 | Beta-sheet mimetics and methods relating to the use thereof | MOLECUMETICS LTD. | 2003-02-06 | — | — | US | disclosed |
| EP-1053246-B1 | BETA-SHEET MIMETICS AND METHODS RELATING TO THE USE THEREOF | MOLECUMETICS LTD (US) | 2003-01-02 | — | — | EP | disclosed |
| US-6372744-B1 | PROTEASE OR KINASE INHIBITORS | MOLECUMETICS LTD. | 2002-04-16 | — | — | US | disclosed |
| EP-1053246-A1 | BETA-SHEET MIMETICS AND METHODS RELATING TO THE USE THEREOF | MOLECUMETICS, LTD. (US) | 2000-11-22 | — | — | EP | disclosed |
| US-6117896-A | Methods for regulating transcription factors | MOLECUMETICS LTD. (US) | 2000-09-12 | — | — | US | disclosed |
| WO-1999041276-A1 | β-SHEET MIMETICS AND METHODS RELATING TO THE USE THEREOF | MOLECUMETICS LTD. (US) | 1999-08-19 | — | — | WO | disclosed |
| EP-0933993-A1 | SUBSTITUTED CYCLOPENTANE COMPOUNDS USEFUL AS NEURAMINIDASE INHIBITORS | BIOCRYST PHARMACEUTICALS INC. (US) | 1999-08-11 | — | — | EP | disclosed |
| EP-0915700-A1 | USE OF BETA-SHEET MIMETICS AS PROTEASE AND KINASE INHIBITORS AND AS INHIBITORS OF TRANSCRIPTION FACTORS | MOLECUMETICS, LTD. (US) | 1999-05-19 | — | — | EP | disclosed |
| WO-1998005333-A1 | USE OF BETA-SHEET MIMETICS AS PROTEASE AND KINASE INHIBITORS AND AS INHIBITORS OF TRANSCRIPTION FACTORS | MOLECUMETICS LTD. (US) | 1998-02-12 | — | — | WO | disclosed |
| WO-1997047194-A1 | SUBSTITUTED CYCLOPENTANE COMPOUNDS USEFUL AS NEURAMINIDASE INHIBITORS | BIOCRYST PHARMACEUTICALS, INC. (US) | 1997-12-18 | — | — | WO | disclosed |
| US-4868165-A | OSTEOPOROSIS | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 1989-09-19 | — | — | US | disclosed |
| EP-0205285-B1 | VITAMIN D3 DERIVATIVES | TAISHO PHARMACEUTICAL CO. LTD (JP) | 1989-08-09 | — | — | EP | disclosed |
| EP-0205285-A1 | Vitamin D3 derivatives | TAISHO PHARMACEUTICAL CO. LTD (JP) | 1986-12-17 | — | — | EP | disclosed |